Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy
Clinical trial NCT02920021 · COMPLETED
Trial details
- NCT number
- NCT02920021
- Sponsor
- AnaptysBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-26
- Primary completion
- 2018-03-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.